ANI Pharmaceuticals
ANIP
ANIP
123 hedge funds and large institutions have $285M invested in ANI Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 41 increasing their positions, 36 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $275M → $285M (+$10.1M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
123
Holding in Top 10
2
Calls
$14.5M
Puts
$9.79M
Top Buyers
| 1 | +$8.29M | |
| 2 | +$7.18M | |
| 3 | +$6.94M | |
| 4 |
Lazard Asset Management
New York
|
+$2.77M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.06M |
Top Sellers
| 1 | -$11.2M | |
| 2 | -$10.3M | |
| 3 | -$9.45M | |
| 4 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
-$6.25M |
| 5 |
CCM
Consonance Capital Management
New York
|
-$4.95M |